CTOs on the Move

Community Eldercare Services

www.cesltc.com

 
Community Eldercare Services, LLC is a Tupelo, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Starr Regional Medical Center

Starr Regional Medical Center will be your trusted source online not only for your hospital information, but also for the time-saving, easy to use, in-depth healthcare information resource you`ll want to refer to frequently. Be active in your healthcare decisions, not a spectator. That`s why we give you access to millions of pages of the most credible, up-to-date medical information available. You can rely on such expert sources as The Merriam Webster Medical Dictionary.

Nussentials

Nussentials is a Eufaula, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Motion Picture and Television Fund

MPTF supports our entertainment community in living and aging well, with dignity and purpose, and in helping each other in times of need.

Diagnostic Centers of America

Diagnostic Centers of America is a Delray Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kymera Therapeutics

Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.